Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022*

Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022*

Wednesday, June 29, 2022
Webinar -- 12:00 PM ET


Program Overview (5 mins)

Key Viral Hepatitis Studies Influencing My Practice Following EASL 2022 (25 mins), including:

  • Current HBV treatment
  • HCV treatment and the care cascade
  • Evolving HDV data
  • Potential HBV cure options
  • Key practice recommendations for the clinic

Question and Answer Session (15 mins)


*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.


Tarik Asselah, MD, PhD

Professor of Medicine
Department of Hepatology
Hôpital Beaujon
Université de Paris
Clichy, France

Goal Statement
The goal of this activity is to improve learners’ competence in translating the most clinically important data from EASL 2022 into practical management strategies for patients with or at risk of viral hepatitis.

Target Audience
This program is intended for physicians, pharmacists, and other healthcare professionals who care for patients with liver diseases.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate the results of recent clinical studies of HBV and HDV management strategies into clinical practice
  • Evaluate the impact of results of clinical studies of investigational treatments for chronic HBV and HDV infection on current and future patient management strategies
  • Implement new data on strategies for optimizing HCV care, including simplified approaches to HCV management


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-22-145-L01-P

Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.